A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 795,700 shares of ORGO stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
795,700
Previous 807,100 1.41%
Holding current value
$2.61 Million
Previous $2.29 Million 2.84%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$2.28 - $3.03 $25,991 - $34,542
-11,400 Reduced 1.41%
795,700 $2.23 Million
Q1 2024

May 13, 2024

SELL
$2.61 - $4.49 $132,131 - $227,306
-50,625 Reduced 5.9%
807,100 $2.29 Million
Q4 2023

Feb 13, 2024

BUY
$1.97 - $4.21 $342,053 - $730,986
173,631 Added 25.38%
857,725 $3.51 Million
Q3 2023

Nov 14, 2023

SELL
$2.34 - $4.43 $51,498 - $97,495
-22,008 Reduced 3.12%
684,094 $2.18 Million
Q2 2023

Aug 11, 2023

SELL
$1.9 - $4.3 $1.03 Million - $2.33 Million
-542,298 Reduced 43.44%
706,102 $2.34 Million
Q1 2023

May 12, 2023

BUY
$1.89 - $2.93 $141,753 - $219,755
75,002 Added 6.39%
1,248,400 $2.66 Million
Q4 2022

Feb 13, 2023

SELL
$2.48 - $3.43 $23,812 - $32,934
-9,602 Reduced 0.81%
1,173,398 $3.16 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $2.23 Million - $4.57 Million
710,800 Added 150.53%
1,183,000 $3.83 Million
Q2 2022

Aug 12, 2022

BUY
$4.74 - $8.15 $599,136 - $1.03 Million
126,400 Added 36.55%
472,200 $2.3 Million
Q1 2022

May 13, 2022

BUY
$6.47 - $9.57 $1.42 Million - $2.11 Million
220,200 Added 175.32%
345,800 $2.64 Million
Q4 2021

Feb 11, 2022

SELL
$9.02 - $13.5 $2.2 Million - $3.29 Million
-244,000 Reduced 66.02%
125,600 $1.16 Million
Q3 2021

Nov 12, 2021

SELL
$13.71 - $17.18 $4.66 Million - $5.83 Million
-339,600 Reduced 47.88%
369,600 $5.26 Million
Q2 2021

Aug 13, 2021

BUY
$14.92 - $23.23 $302,876 - $471,569
20,300 Added 2.95%
709,200 $11.8 Million
Q1 2021

May 13, 2021

BUY
$7.33 - $21.06 $312,258 - $897,156
42,600 Added 6.59%
688,900 $12.6 Million
Q4 2020

Feb 10, 2021

BUY
$3.63 - $7.53 $1.65 Million - $3.42 Million
454,500 Added 236.97%
646,300 $4.87 Million
Q3 2020

Nov 13, 2020

BUY
$3.29 - $4.58 $188,517 - $262,434
57,300 Added 42.6%
191,800 $737,000
Q2 2020

Aug 13, 2020

BUY
$2.86 - $4.61 $191,334 - $308,409
66,900 Added 98.96%
134,500 $516,000
Q1 2020

May 14, 2020

BUY
$2.92 - $5.31 $94,316 - $171,513
32,300 Added 91.5%
67,600 $218,000
Q4 2019

Feb 13, 2020

BUY
$4.7 - $8.11 $165,910 - $286,283
35,300 New
35,300 $170,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $429M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.